Skip to main content

1 Result(s)

within Article Remove this filter **aozhen Xu Remove this filter Medicine & Public Health Remove this filter Hepatology Remove this filter

and

  1. No Access

    Article

    Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

    The burden of chronic hepatitis B infection is high in China, where prevalence exceeds 7 %. This was a randomized, double-blinded, phase III study of the efficacy and safety of telbivudine and lamivudine treat...

    Ji-Dong Jia, **-Lin Hou, You-Kuan Yin, De-Ming Tan, Daozhen Xu… in Hepatology International (2014)